Skip to content
Lower risk Medical device recall · FDA · Published January 14, 2020

Abbott i-STAT G3+ Blue Cartridge Recall: Missing Clinical Evidence

Abbott recalls blue i-STAT G3+ cartridges due to insufficient clinical evidence for safety and performance. All units are affected; stop using immediately to avoid potential risks.

🇺🇸 FDA recall #Z-1265-2020Medical deviceAbbott ›
Take action

Contact the company

Recalling firmAbbott Point Of Care Inc.400 College Rd E · Princeton, NJ 08540-6607
✎ GovInfoNow plain-language explainer

Abbott is recalling all blue i-STAT G3+ cartridges because they were marketed without enough clinical evidence to ensure safety and proper function. This means the cartridges could pose risks if used without the required testing. Read more at govinfonow.com/recall/66049-abbott-i-stat-g3-blue-cartridge-recall-missing-clinical-evidence.

Source Summary by GovInfoNow · govinfonow.com/recall/66049-abbott-i-stat-g3-blue-cartridge-recall-missing-clinical-evidence · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1265-2020

Cite this page

“Abbott i-STAT G3+ Blue Cartridge Recall: Missing Clinical Evidence.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/66049-abbott-i-stat-g3-blue-cartridge-recall-missing-clinical-evidence. Based on FDA recall #Z-1265-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1265-2020%22&limit=1).

The FDA announced on Jan. 14, 2020, that Abbott Point Of Care Inc. is recalling blue i-STAT G3+ cartridges because they were marketed without a 510(k) premarket clearance. The agency stated Abbott lacks sufficient clinical evidence to characterize the performance of these devices.

How to tell if you have it

  • Brand: Abbott
  • Product: i-STAT G3+ cartridge (blue)
  • List No.: 03P78-50
  • UDI (01): 00054749002283
  • UPC: 00054749002283
  • Affected lots: All lots

The hazard

According to the FDA, Abbott Point of Care determined it does not have sufficient clinical evidence to fully characterize the performance of the blue i-STAT G3+ cartridges. Consequently, the company will no longer distribute the product in the United States as of May 1, 2020.

Context

GovInfoNow's records show Abbott Point Of Care Inc. has had 8 other recalls on record since Sept. 12, 2017. Other recent recalls include Abbott i-STAT G3+ Cartridges May Show Wrong Blood Gas Results (April 1, 2026), Abbott i-STAT EG7+ Cartridge Recall: Lack of Premarket Clearance (Aug. 21, 2025), and Abbott i-STAT CG4+ Cartridge Recall: Lack of Premarket Clearance (Aug. 21, 2025). Other recent recalls of similar products include GET TESTED D-Dimer Test Recall (Nov. 3, 2025), Vivoo Test Strips Recall (Nov. 22, 2025), and FreeStyle Libre 14 Day Sensor Recall (Nov. 24, 2025).

How to tell if you have this one

Look for blue i-STAT G3+ cartridges with List No. 03P78-50 and UDI (01) 00054749002283. All lots are affected, so any blue cartridges of this model are included in the recall.

  • Brand
    Abbott
  • Product
    i-STAT G3+ cartridge (blue), List No. 03P78-50, UDI (01) 00054749002283
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    The blue i-STAT G3+ cartridges were recalled due to insufficient clinical evidence for safety and performance. Do not use them.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Jan 14, 202012. FDA classified it Class II: Feb 18, 202023. Published in FDA’s Enforcement Report: Feb 26, 202034. FDA terminated the recall: Apr 12, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1265-2020 (January 14, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1265-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA